康艾注射液联合化疗治疗老年肺癌的效果观察  

Efficacy observation of Kangai injection combined with chemotherapy in treatment of lung cancer in elderly

作　　者：庞世权[1] 陈茵[1] 

机构地区：[1]深圳市宝安区人民医院肿瘤科,深圳518000

出　　处：《中国当代医药》2014年第5期87-88,91,共3页China Modern Medicine

摘　　要：目的 观察康艾注射液联合化疗治疗老年肺癌的临床效果.方法 随机将2010年4月～2012年12月本院收治的60例老年肺癌患者分为实验组和对照组,每组30例.实验组患者应用康艾注射液联合化疗治疗,对照组患者单纯化疗,疗程为1个月,连续3个疗程,观察比较两组的临床疗效、生活质量及不良反应.结果 实验组疾病控制率高于对照组（P＜0.05）,但两组的客观缓解率差异无统计学意义（P＞0.05）；实验组总稳定率为86.7％,对照组总稳定率为56.7％；实验组白细胞下降、血小板减少等不良反应发生率明显低于对照组（P＜0.05）.结论 康艾注射液联合化疗治疗老年肺癌患者,可改善患者的病情,提高自身生活质量,且不良反应较少.Objective To observe the therapeutic effect of Kangai injection combined with chemotherapy in the treatment of lung cancer in elderly.Methods 60 cases of patients with lung cancer who were admitted from April 2010 to December 2012 were divided into experiment goup and control group randomly,each group had 30 cases.Kangai injec- tion combined with chemotherapy was given to the experiment group,and chemotherapy was given to the control group, the course of treatment was one month and three courses were made.The clinical effect,life quality and adverse reaction was compared between the two groups.Results The disease control rate in the experiment group was significantly higher than that in the control group （P〈0.05）,but the objec.tive remission rate had no significant difference between the two groups （P〉0.05）.The total stable rate in the experiment group and control group was 86.7% and 56.7% respectively.The rate of adverse reaction （the decrease of white blood cells,thrombocytopenia） in the experiment group was significantly lower than that in the control group （P〈0.05）.Conclusion The treatment of Kangai injection combined with chemothera- py in the treatment of lun.g cancer in elderly can make the patient＇s condition better, improve the life quality of patient and lower the rate of adverse reaction.

关 键 词：康艾注射液 化疗 肺癌 生活质量 不良反应 

分 类 号：R734.2[医药卫生—肿瘤]